The Director General of the Rwanda Biomedical Centre (RBC), Claude Mambo Muvunyi, has been appointed as a member of the Governing Board of the European & Developing Countries Clinical Trials Partnership (EDCTP), marking another significant milestone for Rwanda’s growing influence in global health research.
The EDCTP is a partnership between European countries and nations in sub-Saharan Africa that works to strengthen clinical research and accelerate the development of innovative health solutions.
The organization focuses particularly on supporting research and clinical trials aimed at preventing, diagnosing, and treating infectious diseases that disproportionately affect populations in Africa.
Prof. Muvunyi’s appointment reflects international recognition of his extensive experience in biomedical research, public health leadership, and Rwanda’s continued commitment to advancing scientific innovation.
Under his leadership, the Rwanda Biomedical Centre has played a pivotal role in strengthening the country’s health systems, expanding research capacity, and fostering collaborations with international institutions.
His inclusion on the EDCTP Governing Board is also seen as a testament to Rwanda’s growing reputation as a regional and global hub for health research.
The country has made significant investments in biomedical science, clinical research, and health innovation, positioning itself as a trusted partner in addressing major public health challenges.
As a member of the Governing Board, Prof. Muvunyi will contribute to shaping the strategic direction of the EDCTP, helping guide investments in collaborative research and innovation that seek to improve health outcomes across sub-Saharan Africa.
The appointment reinforces Rwanda’s increasing role in global scientific partnerships and highlights the country’s dedication to promoting research excellence, strengthening international collaboration, and supporting the development of evidence-based solutions to combat infectious diseases.